September 20, 2016
Combinatorial Screening of Drug Combinations Against Patient Cells: Helping Physicians Identify Personalized Cancer Therapies
There is an increasing trend towards data-driven personalized approaches to drug repositioning. Notable Labs has developed an approach to screen a vast number of combinations of FDA-approved drugs against a cancer patient’s cells to identify actionable, personalized therapies that can be prescribed by their doctor. This webinar featured Transon Nguyen of Notable Labs and Corey McCoy of Biosero, Inc on the combinatorial screening of drug and drug combinations to identify personalized therapies for cancer patients.
How Notable Labs has automated their patient sample processing and combinatorial screening of drugs.
How automation increased throughput, decreased cost and improved patient data quality.
How informatics can plan, execute and automatically analyze data from a screen.
How a rich dataset can expedite the implementation of cost effective treatments for cancer patients.